285 related articles for article (PubMed ID: 1537513)
21. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.
Watanabe Y; Kurata JH; Mizuno S; Mukai M; Inokuchi H; Miki K; Ozasa K; Kawai K
Dig Dis Sci; 1997 Jul; 42(7):1383-7. PubMed ID: 9246033
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study.
Muhsen K; Sinnreich R; Merom D; Nassar H; Cohen D; Kark JD
Hum Genomics; 2019 Jul; 13(1):32. PubMed ID: 31331390
[TBL] [Abstract][Full Text] [Related]
23. Lifestyle factors associated with atrophic gastritis among Helicobacter pylori-seropositive Japanese-Brazilians in São Paulo.
Ito LS; Oba-Shinjo SM; Marie SK; Uno M; Shinjo SK; Hamajima N; Tajima K; Tominaga S
Int J Clin Oncol; 2003 Dec; 8(6):362-8. PubMed ID: 14663638
[TBL] [Abstract][Full Text] [Related]
24. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
25. Variability in serum pepsinogen levels in an asymptomatic population.
Knight T; Greaves S; Wilson A; Hengels K; Newell D; Corlett M; Webb P; Forman D; Elder J
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):647-54. PubMed ID: 8590160
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
27. [Helicobacter pylori and the development of atrophic gastritis].
Takahashi S; Igarashi H; Masubuchi N; Ishiyama N; Saito S; Aoyagi T; Itoh T; Hirata I
Nihon Rinsho; 1993 Dec; 51(12):3231-5. PubMed ID: 8283639
[TBL] [Abstract][Full Text] [Related]
28. Significance of serum pepsinogens and their relationship to Helicobacter pylori infection and histological gastritis in dialysis patients.
Araki H; Miyazaki R; Matsuda T; Gejyo F; Koni I
Nephrol Dial Transplant; 1999 Nov; 14(11):2669-75. PubMed ID: 10534510
[TBL] [Abstract][Full Text] [Related]
29. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
30. Role of Helicobacter pylori in chronic gastritis: a prospective study.
Kudo M; Asaka M; Kato M; Katagiri M; Kagaya H; Nishikawa K; Koshiyama T; Hokari K; Meguro T; Takeda H
J Clin Gastroenterol; 1995; 21 Suppl 1():S174-8. PubMed ID: 8775014
[TBL] [Abstract][Full Text] [Related]
31. Serum pepsinogen I in childhood Helicobacter pylori gastritis: its relation to mucosal peptic activity.
Yahav J; Oderda G; Diver-Haber A; Fradkin A; Keller N; Altare F; Ansaldi N; Jonas A
Isr J Med Sci; 1996 Jan; 32(1):56-9. PubMed ID: 8550350
[TBL] [Abstract][Full Text] [Related]
32. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis.
Hunter FM; Correa P; Fontham E; Ruiz B; Sobhan M; Samloff IM
Dig Dis Sci; 1993 Nov; 38(11):2081-6. PubMed ID: 8223084
[TBL] [Abstract][Full Text] [Related]
33. Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors.
Veenendaal RA; Biemond I; Peña AS; van Duijn W; Kreuning J; Lamers CB
Gut; 1992 Apr; 33(4):452-5. PubMed ID: 1582585
[TBL] [Abstract][Full Text] [Related]
34. Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
Liu H; Fei C; Zhang J
Lab Med; 2021 Jan; 52(1):57-63. PubMed ID: 32702129
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar.
Myint T; Shiota S; Vilaichone RK; Ni N; Aye TT; Matsuda M; Tran TT; Uchida T; Mahachai V; Yamaoka Y
World J Gastroenterol; 2015 Jan; 21(2):629-36. PubMed ID: 25605987
[TBL] [Abstract][Full Text] [Related]
36. Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
Ohkusa T; Takashimizu I; Fujiki K; Araki A; Honda K; Shimoi K; Sakurazawa T; Horiuchi T; Suzuki S; Ariake K; Ishii K
J Clin Gastroenterol; 1997 Jul; 25(1):317-22. PubMed ID: 9412911
[TBL] [Abstract][Full Text] [Related]
37. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
Ricci C; Vakil N; Rugge M; Gatta L; Perna F; Osborn JF; Russo VM; Tampieri A; Bernabucci V; Miglioli M; Vaira D
Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori infection: relationship between seroprevalence and dietary preference in a rural area.
Miyazaki M; Une H; Aoyama H
Acta Med Okayama; 2000 Feb; 54(1):39-44. PubMed ID: 10709621
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
[TBL] [Abstract][Full Text] [Related]
40. High-Negative Anti-
Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
